The Impact of COVID-19 on Pulmonary Procedures
The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- No age limits stated
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "OUTLINE: Participants complete survey over 5-10 minutes."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This survey study looks at how lung procedure programs across the United States changed their work during the COVID-19 pandemic. It is for lung doctors who belong to certain professional groups. The findings may help programs improve their care and guide research for future pandemics.
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Lung doctors who belong to the American Association of Bronchology and Interventional Pulmonology (AABIP), the American College of Chest Physicians (ACCP), or both.
Who can't join
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
Study sites (1)
TX
- M D Anderson Cancer Center · Houston, TX 77030Bruce F. Sabath · Study contact · 240-476-8938 · bsabath@mdanderson.orgBruce F. Sabath · Principal investigatorMore trials in Houston